The CADTH Common Drug Review has issued CDR Update — Issue 136 to provide all stakeholders with the latest program updates.
Highlights in this issue include:
- Details about the updated Canadian Drug Expert Committee meeting schedule.
- An updated Advance Notification Form.
- An update on drug plan participation in pre-submission meetings.
- Details about pending changes to the Key Milestone Table to include the names of patient groups who have provided input on active reviews.
Coming Soon — Updated Submission Guidelines and Procedures
We are currently in the process of updating our Submission Guidelines and Procedure for the CADTH Common Drug Review. See Issue 136 for a preview of the revisions that will be included and watch for the new documents to be posted on our website in June 2018.